Filing Details
- Accession Number:
- 0001127602-15-031209
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-12 19:42:51
- Reporting Period:
- 2015-11-10
- Filing Date:
- 2015-11-12
- Accepted Time:
- 2015-11-12 19:42:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1236397 | Daniel Bradbury | 5200 Illumina Way San Diego CA 92122 | Yes | No | No | No |
Transaction Summary
Sold: | 1,700 shares | Avg. Price: $154.03 | Total Value: $261,845.60 |
Number of Shares After Transactions: | 14,376 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-11-10 | 1,700 | $44.51 | 16,076 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-11-10 | 700 | $153.30 | 15,376 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-11-10 | 800 | $154.40 | 14,576 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-11-10 | 200 | $155.08 | 14,376 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2015-11-10 | 1,700 | $0.00 | 1,700 | $44.51 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,300 | 2013-04-18 | 2022-04-18 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 700 shares sold ranging from $152.99 to $153.65 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 800 shares sold ranging from $154.00 to $154.67 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 200 shares sold ranging from $155.00 to $155.16 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.